Package size
100 Tests, 50 Tests, 25 Tests, 10 Tests, 5 Tests, 100 Tests (N-QC), 50 Tests (N-QC), 25 Tests (N-QC), 10 Tests (N-QC), 5 Tests (N-QC).
Intended use
This device is intended to be used for the in vitro quantitative determination of N-terminal proBNP (NT-proBNP) in human whole blood, serum or plasma. And it is for professional use only, not for self-testing of untrained individuals, nor for near-patient testing.
Summary
The 134-amino acid pre-proBNP produced after stimulation of cardiomyocytes is further converted into a 108-amino acid proBNP. The latter is cleaved under the action of endoproteinase into N-terminal proBNP (NT-proBNP) containing 76 amino acids, which is biologically inactive, and B-type natriuretic peptide (BNP) containing 32 amino acids, which is active. NT-proBNP is mainly synthesized by left ventricular cardiomyocytes, secreted into the blood, and filtered mainly by glomeruli. Therefore, its blood concentration is affected by renal function. As an effective heart failure marker, NT-proBNP can independently predict the increased ventricular pressure. It is of great value in the auxiliary diagnosis, treatment evaluation and monitoring for congestive heart failure, dyspnea complications caused by congestive heart failure, the essential hypertension, left ventricular dysfunction and other cardiovascular-related diseases.
The current clinical methods for detecting NT-proBNP include double antibody sandwich immunoluminescence method, colloidal gold colorimetry, colloidal gold immunochromatography and so on.
PRODUCT PARAMETER
|
TEST INFORMATION |
|||
|
Method |
Microfluidic Fluorescent Immunoassay |
Test |
LYOFIA® NT-proBNP |
|
Format |
Cassette |
Reaction Time |
10min |
|
Linearity |
30～35000pg/mL |
Reference Interval |
≤300pg/mL |
|
Sample |
WB / S / P |
Certificate |
CE / NMPA |
|
ORDERING |
|||||
|
Cat. No. |
LMCMNT25 |
Applicable analyzer |
LYOFIA-I, LYOFIA 8, |
Kit Size |
25T |
|
Cat. No. |
LACMNT25 |
Applicable analyzer |
LYOFIA 100 (Full-Automatic) |
Kit Size |
25T |
APPLICATION SCENARIOS
Hospitals
Laboratory
Clinics
Ambulance
Cardiology
Pediatrics
Emergency
CSC
FAQ
Q: Are the results of CRP, SAA whole blood and peripheral blood the same?
A: Our laboratory big data test results show that the test results of CRPSAA on whole blood and fingertip blood are consistent. In the process of detecting fingertip blood, the inspecting doctor should try to avoid inhaling impurities such as subcutaneous tissue, which may lead to deviations in the test results.
This question is placed under the two products of CRP and SAA.
Q: Is it possible to add emergency testing to our instrument in the middle of the testing process?
A: LYOFIA 100, DISKFLU 1000, these two instruments can achieve.
This question is placed under LYOFIA 100, DISKFLU 1000, these two products.
Hot Tags: n-terminal probnp (nt-probnp) test kit, China, suppliers, manufacturers, factory, pricelist, quotation
